Valuation: Ipca Laboratories Limited

Market Cap 411B 4.35B 3.82B 3.52B 3.29B 6.18B 6.3B 42.28B 16.36B 203B 16.34B 15.99B 704B P/E 2026
35.6x
P/E 2027 * 29.4x
Enterprise Value 406B 4.3B 3.77B 3.47B 3.25B 6.1B 6.23B 41.76B 16.16B 200B 16.14B 15.79B 695B EV / Sales 2026
4.24x
EV / Sales 2027 * 3.68x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.36%
1 day-0.18%
1 week+2.05%
Current month+6.16%
1 month+2.55%
3 months+3.08%
6 months+12.40%
Current year+14.05%
1 week 1,582.4
Extreme 1582.4
1,655
1 month 1,470
Extreme 1470
1,670
Current year 1,391.8
Extreme 1391.8
1,678.3
1 year 1,251.6
Extreme 1251.6
1,678.3
3 years 734.1
Extreme 734.1
1,755.9
5 years 669.8
Extreme 669.8
1,755.9
10 years 200
Extreme 200
1,755.9
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+2.05%+20.36%+118.54% 4.35B
+7.13%+9.97%+51.94%+166.83% 1,077B
+3.99%+11.50%+67.53%+55.63% 613B
+4.20%+17.03%+35.63%+87.74% 448B
+0.99%+4.85%+27.93%+22.82% 332B
+1.82%+8.19%+41.15%+26.80% 293B
+0.22%+6.75%+31.51%+42.02% 286B
+0.73%+8.53%-26.22%-40.85% 215B
+1.56%+6.14%+28.38%+59.45% 193B
+3.26%+3.33%+18.83%+67.03% 159B
Average +1.84%+7.68%+29.70%+60.60% 362.04B
Weighted average by Cap. +2.26%+8.92%+40.49%+81.33%

Financials

2026 2027 *
Net sales 96.62B 1.02B 898M 828M 775M 1.45B 1.48B 9.95B 3.85B 47.75B 3.85B 3.76B 166B 108B 1.14B 1B 923M 864M 1.62B 1.65B 11.09B 4.29B 53.24B 4.29B 4.19B 185B
Net income 11.21B 119M 104M 96.02M 89.9M 169M 172M 1.15B 447M 5.54B 446M 436M 19.21B 14.04B 149M 130M 120M 113M 211M 216M 1.45B 559M 6.94B 559M 547M 24.06B
Net Debt -5.02B -53.18M -46.63M -42.98M -40.24M -75.46M -77.03M -517M -200M -2.48B -200M -195M -8.6B -14.5B -154M -135M -124M -116M -218M -223M -1.49B -578M -7.16B -577M -564M -24.84B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
25/06/26 INR 1,618.30 -0.18% 167,145
24/06/26 INR 1,621.20 -0.23% 116,670
23/06/26 INR 1,625.00 +1.73% 179,904
22/06/26 INR 1,597.30 +0.73% 86,624
19/06/26 INR 1,585.80 +2.73% 262,446
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,618.30INR
Average target price
1,719.61INR
Spread / Average Target
+6.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock